Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Prevention of Post-Traumatic Epilepsy
NCT00566046Phase 3Terminated
- Sponsor
- CHU Rennes
- Start
- Nov 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-traumatic epilepsy (PTE) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Time to early epileptic seizures and late epilepsy at 1 year. Started Nov 2007; status: terminated.
02
Drugs
levetiracetam
03
Conditions
post-traumatic epilepsy (PTE)
Beyond the preview
Go deeper on NCT00566046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566046.